— Item 28 of 29 = y Mark <I e a i @ al

— " . L
Question Id: 1171 Praras Next FullScreen Tutorial__—_Lab Values

A 73-year-old man comes to the office for follow-up. He was diagnosed with chronic
lymphocytic leukemia (CLL) 3 years ago when routine laboratory testing revealed a markedly
elevated leukocyte count. He feels well. On examination, he has stable lymphadenopathy.
He has been reading about management options should his CLL progress and inquires about
an experimental drug that selectively binds malignant lymphocytes. The drug has been shown
to significantly prolong survival in patients with stage 3 and 4 CLL, without curing the
malignancy. If this new drug were widely used, what changes would be expected in the
number of incident and prevalent cases of CLL?

() A. The number of incident cases will decrease, the number of prevalent cases will
decrease

©) B. The number of incident cases will increase, the number of prevalent cases will not
change

|) C. The number of incident cases will decrease, the number of prevalent cases will
increase

() D. The number of incident cases will not change, the number of prevalent cases will

increase

Block Time Elapse
Tutor

Notes

Calculator

e @A 8

Reverse Color _Text Zoom Settings

End Block
